Terms: = Lymphoma AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
1649 results:
1. Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects.
Li J; Mu J; Wang J; Li X; Li Q; Jiang Y; Cui R; Deng Q
Cell Transplant; 2024; 33():9636897241247951. PubMed ID: 38651796
[TBL] [Abstract] [Full Text] [Related]
2. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell lymphoma.
Zhang Y; Chen Y; Guo Q; Zhang Y; Liu A
Discov Med; 2024 Mar; 36(182):621-631. PubMed ID: 38531803
[TBL] [Abstract] [Full Text] [Related]
3. Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma.
Xiong J; Cheng S; Gao X; Yu SH; Dai YT; Huang XY; Zhong HJ; Wang CF; Yi HM; Zhang H; Cao WG; Li R; Tang W; Zhao Y; Xu PP; Wang L; Zhao WL
Signal Transduct Target Ther; 2024 Mar; 9(1):62. PubMed ID: 38448403
[TBL] [Abstract] [Full Text] [Related]
4. A novel β-cyclodextrin-assisted enhancement strategy for portable and sensitive detection of miR-21 in human serum.
Yao F; Wu L; Xiong Y; Su C; Guo Y; Bulale S; Zhou M; Tian Y; He L
Anal Methods; 2024 Mar; 16(11):1639-1648. PubMed ID: 38414387
[TBL] [Abstract] [Full Text] [Related]
5. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations.
Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA
Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126
[TBL] [Abstract] [Full Text] [Related]
6. Similar geographic distribution of mortality from multiple sclerosis, Hodgkin lymphoma, and inflammatory bowel disease in the United States.
Sonnenberg A
Mult Scler Relat Disord; 2024 Apr; 84():105493. PubMed ID: 38354444
[TBL] [Abstract] [Full Text] [Related]
7. An anti-CD19/ctla-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.
Prinz LF; Riet T; Neureuther DF; Lennartz S; Chrobok D; Hübbe H; Uhl G; Riet N; Hofmann P; Hösel M; Simon AG; Tetenborg L; Segbers P; Shimono J; Gödel P; Balke-Want H; Flümann R; Knittel G; Reinhardt HC; Scheid C; Büttner R; Chapuy B; Ullrich RT; Hallek M; Chmielewski MM
Cell Rep Med; 2024 Feb; 5(2):101421. PubMed ID: 38340727
[TBL] [Abstract] [Full Text] [Related]
8. Clinical Characteristics and Local Histopathological Modulators of Endometriosis and Its Progression.
Istrate-Ofiţeru AM; Mogoantă CA; Zorilă GL; Roşu GC; Drăguşin RC; Berbecaru EI; Zorilă MV; Comănescu CM; Mogoantă SȘ; Vaduva CC; Brătilă E; Iliescu DG
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339066
[TBL] [Abstract] [Full Text] [Related]
9. Automated classification of ulcerative lesions in small intestine using densenet with channel attention and residual dilated blocks.
Guo X; Xu L; Liu Z; Hao Y; Wang P; Zhu H; Du Y
Phys Med Biol; 2024 Feb; 69(5):. PubMed ID: 38316034
[No Abstract] [Full Text] [Related]
10. A case report: Castleman disease treated by the trinity of internal and external treatment of "Fuzheng, phlegm-resolving, and detoxification method".
Yuan X; Fu H; Xu M; Shen W; Zhou W; Li X; Gan X
Medicine (Baltimore); 2024 Feb; 103(5):e37110. PubMed ID: 38306555
[TBL] [Abstract] [Full Text] [Related]
11. Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma.
Pirosa MC; Stathis A; Zucca E
Hum Vaccin Immunother; 2024 Dec; 20(1):2309701. PubMed ID: 38299612
[TBL] [Abstract] [Full Text] [Related]
12. Therapy of Castleman's disease with siltuximab - case report and review of literature.
Adam Z; Zeman D; Chodacki A; Pour L; Horváth T; Benda P; Adamová Z; Krejčí M; Tomíška M; Boichuk I; Král Z
Klin Onkol; 2023; 37(4):320-329. PubMed ID: 38195387
[TBL] [Abstract] [Full Text] [Related]
13. Monomorphic epitheliotropic intestinal T-cell lymphoma involving the central nervous system: a rare case report with comprehensive autopsy neuropathological examinations.
Talabong DJA; Laguerre E; Chen NN; Zeng J
J Hematop; 2023 Sep; 16(3):155-160. PubMed ID: 38175405
[TBL] [Abstract] [Full Text] [Related]
14. Maintenance therapy for chronic lymphocytic leukaemia.
Lee CH; Wu YY; Huang TC; Lin C; Zou YF; Cheng JC; Chen PH; Jhou HJ; Ho CL
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013474. PubMed ID: 38174814
[TBL] [Abstract] [Full Text] [Related]
15. TIGIT is Frequently Expressed in the Tumor Microenvironment of Select lymphomas: Implications for Targeted Therapy.
Libert D; Zhao S; Younes S; Mosquera AP; Bharadwaj S; Ferreira C; Natkunam Y
Am J Surg Pathol; 2024 Mar; 48(3):337-352. PubMed ID: 38148663
[TBL] [Abstract] [Full Text] [Related]
16. Advanced enteropathy-associated T cell lymphoma (EATL) presenting with severe malabsorption and concomitantly diagnosed coeliac disease (CD).
Rajagopal A; Thompson CA; Chorzempa AK; Ryu AJ
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38142052
[TBL] [Abstract] [Full Text] [Related]
17. Pediatric-type follicular lymphoma in a Crohn's disease patient receiving anti-α4β7-integrin therapy: A case report.
Yerigeri K; Buhtoiarov I
World J Gastroenterol; 2023 Nov; 29(43):5865-5871. PubMed ID: 38074918
[TBL] [Abstract] [Full Text] [Related]
18. [Multimodal ultrasound techniques for the differential diagnosis of splenic lesions - A diagnostic challenge].
Stock KF; Slotta-Huspenina J; Findeisen H; Görg C
Chirurgie (Heidelb); 2023 Dec; 94(12):1000-1008. PubMed ID: 38010420
[TBL] [Abstract] [Full Text] [Related]
19. The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.
Pelliccia S; Rogges E; Cardoni A; Lopez G; Conte E; Faccini AL; De Vito R; Girardi K; Bianchi A; Annibali O; Fratoni S; Remotti D; De Angelis G; Giordano C; Palumbo G; Scarpino S; Del Porto F; Bianchi MP; Di Gregorio F; Tafuri A; Di Napoli A
Br J Haematol; 2024 Feb; 204(2):534-547. PubMed ID: 37953489
[TBL] [Abstract] [Full Text] [Related]
20. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
[TBL] [Abstract] [Full Text] [Related]
[Next]
